Fragrance Compositions

A fragrance composition comprising at least 75% by weight of perfume materials drawn from the following groups:

• A) at least 10% by weight in total of at least three materials drawn from Group ‘IMP’, wherein Group ‘IMP’ comprises:
• allyl amyl glycolate;
• benzyl salicylate;
• bergamot oil;
• coriander oil;
• cyclamen aldehyde;
• 1-(2,6,10-trimethylcyclododeca-2,5,9-trien-1-yl)ethanone;
• prop-2-enyl (cyclohexyloxy)acetate;
• Damascenia 185 SAE;
• 2,4-dimethylheptan-1-ol;
• fir balsam;
• fir needle oil;
• 3-(4-ethylphenyl)-2,2-dimethylpropanal;
• ginger oil;
• guaiacwood;
• linalyl acetate;
• litsea cubeba oil;
• methyl 2,4-dihydroxy-3,6-dimethylbenzoate;
• nutmeg oil;
• olibanum oil;
• orange flower oil;
• Ozonal AB 7203C;
• patchouli oil;
• rose oxide;
• rosemary oil;
• sage clary oil;
• spearmint oil;
• Tamarine AB 8212E;
• and tarragon oil;
• B) optionally up to 90% of materials from the following groups:
• Group ‘HMR’ comprising:
• allyl ionone;
• benzyl acetate;
• cis-jasmone;
• citronellol;
• ethyl linalol;
• ethylene brassylate;
• 4-methyl-2-(2-methylpropyl)tetrahydro-2H-pyran-4-ol;
• geraniol;
• geranium oil;
• iso-eugenol;
• lemon oil;
• 3-(4-hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde;
• 4-(4-hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde;
• alpha-iso-methyl ionone;
• 3-methylcyclopentadec-2-en-1-one;
• cyclopentadecanone;
• cyclohexadecanolide;
• and gamma-undecalactone;
• Group ‘HMI’ comprising:
• 1-{[2-(1,1-dimethylethyl)cyclohexyl]oxy}butan-2-ol;
• 3a,6,6,9a-tetramethyldodecahydronaphtho[2,1-{b}]furan;
• alpha-damascone;
• dihydromyrcenol;
• eugenol;
• 3-(1,3-benzodioxol-5-yl)-2-methylpropanal;
• 2,4-dimethylcyclohex-3-ene-1-carbaldehyde;
• mandarin oil;
• orange oil;
• and 2-(1,1-dimethylethyl)cyclohexyl acetate;
• Group ‘HMP’ comprising:
• 1-(2,6,6,8-tetramethyltricyclo[5.3.1.0{1,5}]undec-8-en-9-yl)ethanone;
• allyl cyclohexylpropionate;
• allyl heptanoate;
• Apple Oliffac S pcmf;
• 7-methyl-2H-1,5-benzodioxepin-3(4H)-one;
• cassis base;
• cis-3-hexenyl salicylate;
• damascenone;
• gamma-decalactone;
• ethyl acetoacetate;
• ethyl maltol;
• ethyl methyl phenylglycidate;
• hexyl acetate;
• (3E)-4-methyldec-3-en-5-ol;
• 2,5,5-trimethyl-6,6-bis(methyloxy)hex-2-ene;
• 4-(4-hydroxyphenyl)butan-2-one;
• styrallyl acetate;
• 2,2,5-trimethyl-5-pentylcyclopentanone;
• and ylang oil;
• Group ‘RMP’ comprising:
• anisic aldehyde;
• (2Z-2-ethyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)but-2-en-1-ol;
• benzoin siam resinoid;
• ethyl vanillin;
• oxacyclohexadec-12(13)-en-2-one;
• hexyl salicylate;
• hydroxycitronellal;
• jasmin oil;
• 3-methyl-5-phenylpentan-1-ol;
• 2-(phenyloxy)ethyl 2-methylpropanoate;
• alpha-terpineol;
• and vanillin;
• Group ‘GEN’ comprising:
• cyclopentadecanolide;
• hexyl cinnamic aldehyde;
• ionone beta;
• isobornyl cyclohexanol;
• 1-(2,3,8,8-tetramethyl-1,2,3,4,5,6,7(8),8(8a)-octahydronaphthalen-2-yl)ethanone;
• 3-[4-(1,1-dimethylethyl)phenyl]-2-methylpropanal;
• linalol;
• methyl dihydrojasmonate;
• and 2-phenylethanol;
• provided the following conditions (a) through (e) are met:
• (a) IMPs>=HMPs+HMRs;
• (b) IMPs+HMIs+GENs>=70%;
• (c) (IMP+HMI)/(IMP+HMI+RMP+HMR)>=0.7;
• (d) IMPs/(HMPs+RMPs+IMPs)>=0.5;
• and
• (e) IMPs/[(HMPs+RMPs+IMPs)+(100−TOTAL)]>=0.3,
• wherein ‘IMPs’ indicates the sum of the percentages of materials within Group IMP, and similarly for the remaining groups, the symbol ‘>=’ indicates ‘at least equal to’, and ‘TOTAL’ is the sum of HMPs, HMRs, HMIs, IMPs, RMPs and GENs, provided also that low odour or no odour solvents are excluded from the calculation of these sums.